Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixi

First Page		Document Content
Date: 2015-06-08 18:15:35 Monoclonal antibodies Immunosuppressants Centocor Infliximab Schering-Plough Autoimmune diseases Pregnancy TNF inhibitor Vaccine Medicine Biology Health		Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixi Add to Reading List Source URL: www.mothertobaby.org Download Document from Source Website File Size: 367,52 KB Share Document on Facebook

	UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol DocID: 1rakB - View Document
	JUNE 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qDC6 - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qs3R - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qius - View Document
	FEBRUARY 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qcKs - View Document